ArticleCureus2025
H7 Coil Deep Repetitive Transcranial Magnetic Stimulation in Patients With Obsessive-Compulsive Disorder: Do Factors Like Age, Sex, and Medication Affect Clinical Outcomes?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repetitive transcranial magnetic stimulation treatment for obsessive-compulsive disorder.Current opinion in psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Deep repetitive transcranial magnetic stimulation (DTMS), using the H7 coil, is an approved treatment for obsessive-compulsive disorder (OCD) by the United States Food and Drug Administration (US-FDA). The clinical efficacy and safety of accelerated regimens of DTMS have been previously studied extensively. This study reiterates the efficacy of accelerated DTMS (aDTMS) and examines the influence of factors such as age, sex, and medication on clinical outcomes in the Indian population. Methods A retrospective data analysis of 378 OCD patients was conducted. aDTMS sessions were given as a combination of intermittent theta burst stimulation (iTBS) and high-frequency stimulation (HFS) over eight days, with two sessions per day. The primary outcome measure was the Yale-Brown Obsessive-Compulsive Scale (YBOCS) scores, assessed before and after 15 sessions of aDTMS. Results A significant mean reduction in Day 8 YBOCS scores (11.12 ± 7.46, Cohen's d = 2.2, p < 0.0001), with an overall response rate of 64.72% and a remission rate of 46.12%, was observed (N = 378). The study also found that patients of both sexes, aged 30-44 years, showed the highest response to treatment. Women with severe to extreme disease, and menopausal women, did not respond better than men. The number of drugs had no significant effect on the outcome. Conclusions The findings support the potential of aDTMS as an effective adjunctive treatment for OCD, highlighting the interplay of various factors in determining clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.